SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-006168
Filing Date
2024-02-22
Accepted
2024-02-22 09:01:43
Documents
8
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 a2023s-8.htm S-8 93710
2 EX-FILING FEES s-82023exhibit107.htm EX-FILING FEES 30042
3 EX-5.1 s-82023xexhibit51.htm EX-5.1 6643
4 EX-23.2 s-82023xexhibit232.htm EX-23.2 2607
5 image_10.jpg GRAPHIC 90
6 image_11.jpg GRAPHIC 204
7 image_7.jpg GRAPHIC 100
8 image_9.jpg GRAPHIC 109
  Complete submission text file 0001628280-24-006168.txt   135225
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277245 | Film No.: 24662481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)